COMPARISON OF SWITCHING TO REDUCED DOSE VS CONTINUATION OF STANDARD DOSE ETANERCEPT FOR RHEUMATOID ARTHRITIS PATIENTS IN THE CORRONA REGISTRY

被引：2
|
作者：
Greenberg, J. D. [1 ,2 ]
Shan, Y. [2 ]
Reed, G. W. [2 ,3 ]
Bitman, B. [4 ]
Collier, D. [5 ]
机构：
[1] NYU, Sch Med, New York, NY USA
[2] CORRONA Inc, Southborough, MA USA
[3] Univ Massachusetts, Sch Med, Worcestesr, MA USA
[4] Amgen Inc, San Francisco, CA USA
[5] Amgen Inc, Thousand Oaks, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.1836
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0174
引用
收藏
页码：241 / 241
页数：1
相关论文
共 50 条
  • [21] DIFFERENT STRATEGIES OF LOW DOSE ETANERCEPT IN RHEUMATOID ARTHRITIS PATIENTS IN SUSTAINED REMISSION
    Bernardi, L.
    Ornetto, F.
    Botsios, K.
    Punzi, L.
    Raffeiner, B.
    Doria, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1036 - 1036
  • [22] Infliximab, etanercept and adalimumab switching in patients with rheumatoid arthritis in the consortium of rheumatology researchers of North America (CORRONA) database.
    Dabbous, O.
    Kremer, J.
    El Taha, M.
    Reed, G.
    Tang, B.
    Arjunji, R.
    Thompson, H.
    Rahman, M. I.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S705 - S705
  • [23] A comparison of treatment outcomes in patients receiving standard dose vs. reduced dose proton radiation for uveal melanoma
    Oxenreiter, Monica
    Lane, Anne Marie
    Kim, Ivana
    Gragoudas, Evangelos S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [24] Comparison of joint destruction between standard- and low-dose etanercept in rheumatoid arthritis from the Prevention of Cartilage Destruction by Etanercept (PRECEPT) study
    Tada, Masahiro
    Koike, Tatsuya
    Okano, Tadashi
    Sugioka, Yuko
    Wakitani, Shigeyuki
    Fukushima, Kenzo
    Sakawa, Akira
    Uehara, Kazunori
    Inui, Kentaro
    Nakamura, Hiroaki
    RHEUMATOLOGY, 2012, 51 (12) : 2164 - 2169
  • [25] A Pilot Dose-Finding Study of Etanercept in Rheumatoid Arthritis
    Breedveld, Ferdinand C.
    Jones, Heather E.
    Peifer, Kim
    Korth-Bradley, Joan
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2018, 11 (01): : 38 - 45
  • [26] A Dose-Finding Study of Etanercept for Treatment of Rheumatoid Arthritis
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (01) : 13 - 13
  • [27] Maintenance of Sustained Low Disease Activity or Remission in Patients With Rheumatoid Arthritis Treated With Etanercept Monotherapy: Results from the Corrona Registry
    Pappas, Dimitrios A.
    Shan, Ying
    Lesperance, Tamara
    Kricorian, Greg
    Karis, Elaine
    Rebello, Sabrina
    Hua, Winnie
    Accortt, Neil A.
    Stryker, Scott
    ACR OPEN RHEUMATOLOGY, 2020, 2 (10) : 588 - 594
  • [28] Correction to: The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis
    Fangfang Chen
    Yitian Lang
    Shikai Geng
    Xiaodong Wang
    Liangjing Lu
    Shuang Ye
    Le Zhang
    Ting Li
    Clinical Rheumatology, 2023, 42 : 2923 - 2923
  • [29] DOSE REDUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RESPONDING TO THE STANDARD RITUXIMAB REGIMEN
    Batticciotto, A.
    Varisco, V.
    Antivalle, M.
    Talotta, R.
    Rigamonti, F.
    Ventura, D.
    Atzeni, F.
    Sarzi-Puttini, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 877 - 877
  • [30] Effects of half dose etanercept (25 mg once a week) on clinical remission and radiographic progression in patients with rheumatoid arthritis in clinical remission achieved with standard dose
    Raffeiner, B.
    Botsios, C.
    Ometto, F.
    Bernardi, L.
    Stramare, R.
    Todesco, S.
    Sfriso, P.
    Punzi, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (01) : 63 - 68
12345